Greg Halperin is a trial lawyer with experience spanning more than 170 trial days. He has particular expertise representing clients in the life sciences industry in complex product liability and mass tort litigation.

As a member of eight trial teams, Greg has experience crafting opening statements and closing arguments, and examining key fact and expert witnesses at trial. Greg was a member of the team that tried the first opioids case involving wholesale distributors to verdict, resulting in a complete defense win. He also participated in trial wins involving Pradaxa and Roundup.

Greg is skilled in all stages of litigation, including taking and defending depositions, preparing witnesses, and drafting Daubert and dispositive motions. He has argued numerous motions in state and federal court, including recently in the first multi-plaintiff trial in St. Louis involving allegations that Roundup causes non-Hodgkin’s lymphoma. He also represents clients on appeal and has authored amicus briefs before the United States Supreme Court.

Greg has received numerous accolades for his accomplishments in product liability and mass tort litigation. He has been recognized as a “Rising Star” by Law360 and New York Metro Super Lawyers, and included on Best Lawyers’ “Ones to Watch” list. He was also recognized as an Outstanding Contributor by Lawyers for Civil Justice for his efforts to reform the procedural rules governing mass tort litigation.

Greg joined Covington following a clerkship with the Honorable Paul V. Niemeyer on the United States Court of Appeals for the Fourth Circuit. Prior to his clerkship, Greg graduated magna cum laude from Harvard Law School, where he served as an Executive Editor of the Harvard Law Review.